Navigation Links
VetStem Biopharma Regenerative Cell Therapy Has Been Used on over 12,000 Animals
Date:6/6/2016

The leading Regenerative Veterinary Medicine Company, VetStem Biopharma, is proud to announce that its regenerative stem cell therapy has been used on more than 12,000 animals. VetStem was founded in 2002, seeking to discover a successful treatment for horses with potentially fatal injuries to tendons and ligaments.

In 2003 VetStem signed a worldwide exclusive license for adipose-derived (fat derived) stem cell technology for veterinary applications, and the first horse was treated in September 2003. In mid 2005, the first dogs were treated with VetStem Regenerative Cell Therapy. VetStem started providing stem cell banking to their clients early in their history so that cells could be stored for future use. By August of 2005 500 horses had been treated. VetStem had effectively introduced a new, natural, injectable treatment to the equine and small animal veterinary industry that could serve as an alternative to euthanasia for some conditions.

Although the large majority of animals treated have been horses, dogs and cats, VetStem has provided services for exotic species as well. The U.S. Navy, Office of Naval Research, awarded VetStem a contract to engage in a collaborative study of stem cell biology in marine mammals in 2009. From this, the first peer-reviewed article was published showing successful isolation of stem cells from dolphin fat. Several media outlets featured a story on a panther from the Tallahassee Museum who received stem cell services through VetStem for arthritis of the elbow in 2011. After the therapy he was able to stand up and scratch on his favorite tree with both front paws. VetStem has also worked with Zoos and Aquariums across the United States to help them treat their residents. We work diligently with each of the agencies to help provide the best care possible.

VetStem continues to strive to bring the best Regenerative Medicine therapies to the market to help provide a better quality of life for animals. Dr. Robert Harman, CEO and Founder of VetStem has spoken at many human and veterinary conferences sharing the results of real treatments. He has also authored or co-authored numerous peer-reviewed papers on stem cells as well as written book chapters on stem cells.

“I started VetStem in order to help horses with career ending injuries to their tendons and ligaments but so many more animals have been saved from a life of pain or even from euthanasia. I am excited to see that even after 14 years we are still leading the way in Regenerative Medicine,” Robert Harman, DVM, CEO and Founder of VetStem.

About VetStem Biopharma
VetStem Biopharma is a veterinarian-lead company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 12 years and 11,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 55 issued patents in the field of regenerative medicine.

Read the full story at http://www.prweb.com/releases/2016/06/prweb13456787.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma
2. VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples
3. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services.
4. West Coast Bird Dog Champion Wins US Bird Dog Association Western States National Flushing Champion with the help of Stem Cell Therapy by VetStem.
5. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma, Announces the Addition of Dr Ross Rich as the Director of Clinical Development
6. VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering
7. VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities.
8. VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center.
9. VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour
10. VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product
11. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to be a Guest Speaker at MSC 2015 Adult Stem Cell Therapy & Regenerative Medicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... ... August 13, 2019 , ... Chata was ... for QC laboratories. After gaining a few significant clients, Lifecycle purchased the company ... valued supplier of manufacturing processing solutions, including reagents for tissue processing. Chata quickly ...
(Date:8/7/2019)... ... August 07, 2019 , ... Locus Agricultural Solutions (Locus AG) reports ... amendments (soil “probiotics”), including Rhizolizer ® , which is pulling up to 121% ... approach has offered to date. Results from the treatment of almonds, cherries, turf/sod, grapes ...
(Date:8/6/2019)... ... 06, 2019 , ... Shoreline Biome, a microbiome ... level, has announced partnerships with six international distributors. , The distributors will ... in Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, the United Kingdom, ...
(Date:8/6/2019)... Ill. (PRWEB) , ... August 06, 2019 , ... ... Southern Illinois University Edwardsville for the launch of a community project that will ... The three-year grant supports the project, entitled “A Youth-Led Citizen Science Network for ...
Breaking Biology Technology:
(Date:9/14/2019)... ... September 12, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... biologics business. Dr. Schaffer has played an integral advisory role on the gene ...
(Date:9/11/2019)... ... ... Greenberg Traurig, LLP attorneys Stephen Baird , - Marcella C. ... 9-10, at the Hyatt Regency, Minneapolis. Greenberg Traurig is a founding sponsor of DeviceTalks, ... have been featured speakers at every DeviceTalks conference since 2011. , On Sept. 9, ...
(Date:9/8/2019)... ... September 06, 2019 , ... RoosterBio, ... stem/stromal cell (hMSC) biomanufacturing systems, today announces its release of the Regenerative ... system designed for product development. RoosterBio continues to simplify MSC production by ...
Breaking Biology News(10 mins):